Your browser is no longer supported. Please, upgrade your browser.
APOP Cellect Biotechnology Ltd. daily Stock Chart
APOP [NASD]
Cellect Biotechnology Ltd.
Index- P/E- EPS (ttm)-0.85 Insider Own54.73% Shs Outstand0.45M Perf Week5.14%
Market Cap1.17M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float- Perf Month-7.82%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter3.95%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.02 Perf Half Y-11.40%
Book/sh0.69 P/B3.79 EPS next Y- ROA- Target Price12.00 Perf Year-83.99%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range1.58 - 19.15 Perf YTD-75.07%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-86.21% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low67.14% ATR0.25
Employees28 Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)53.71 Volatility8.16% 9.06%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.22 Prev Close2.62
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume234.30K Price2.64
Recom- SMA201.17% SMA506.12% SMA200-19.23% Volume48,840 Change0.87%
Sep-25-17Reiterated H.C. Wainwright Buy $12 → $14
Nov-19-19 07:00AM  Cellect Biotechnology Reports Third Quarter 2019 Financial and Operating Results PR Newswire
Nov-11-19 06:29AM  Does Market Volatility Impact Cellect Biotechnology Ltd.'s (NASDAQ:APOP) Share Price? Simply Wall St. +5.88%
Nov-07-19 08:00AM  Cellect Biotechnology Regains Compliance With Nasdaq Minimum Bid Price Requirement PR Newswire -13.88%
Aug-13-19 12:28PM  A Look At Benzinga Pro's Most-Searched Tickers For August 13, 2019 Benzinga -10.34%
08:00AM  Cellect Biotechnology Reports Second Quarter 2019 Financial and Operating Results PR Newswire
Aug-12-19 11:35AM  Cellect Shares Rally After Lead Stem Cell Program Receives Clearance For Midstage Study Benzinga +39.76%
07:00AM  Cellect Biotechnology Announces Positive Outcome From Safety Review Committee; Successfully Transplants 9th Clinical Trial Patient PR Newswire
Jul-08-19 07:00AM  Cellect Biotechnology and Washington University (WU) Finalize Accelerated Clinical Trial Agreement PR Newswire -6.43%
May-21-19 07:00AM  Cellect Biotechnology Reports First Quarter 2019 Financial and Operating Results PR Newswire
May-16-19 07:00AM  Cellect Biotechnology to Explore Strategic Alternatives to Maximize Shareholder Value GlobeNewswire -8.15%
07:00AM  Cellect Biotechnology Announces Receipt of Nasdaq Minimum Bid Price Notification GlobeNewswire
Mar-27-19 08:00AM  Cellect Announces Positive Phase I/II Mid-Study Results of Its ApoGraft Technology PR Newswire
Mar-18-19 04:15PM  Cellect Biotechnology Reports Fourth Quarter and Full Year 2018 Results and Recent Corporate Progress PR Newswire
Mar-12-19 08:15AM  Stem Cell Collaboration Results Push Cellect Biotechnology Shares Higher, Full Analysis ACCESSWIRE -5.49%
Mar-11-19 09:35AM  Four Healthcare Stocks Making Moves on Monday ACCESSWIRE +9.96%
07:00AM  Cellect Announces Positive Results From Cell2in Collaboration Showing Significant Improvement in Expansion Rate and Function of Stem Cells PR Newswire
Feb-13-19 05:00PM  Cellect Announces Closing of $6.5 Million Underwritten Public Offering GlobeNewswire
Feb-08-19 12:55AM  Cellect Announces Pricing of $6.5 Million Public Offering GlobeNewswire -49.78%
Feb-05-19 07:30AM  Cellect Begins Collaboration with Washington University in Preparation for First U.S. Clinical Trial Using Cellect's ApoGraft for Bone Marrow Transplantations PR Newswire -9.72%
Jan-28-19 07:00AM  Completion of Manufacturing of Clinical Grade FasL Enables Cellect to Expedite U.S. Clinical Programs into Multiple Studies PR Newswire -7.41%
Jan-23-19 07:20AM  Cellect Biotechnology Reports Clinical and Regulatory Milestone Targets PR Newswire
Dec-17-18 07:00AM  Further to the Announcement of the Agreement Signed With the South Korean Cell2in: KORIL Approves Cellect's Grant Application PR Newswire -11.03%
Nov-21-18 08:45AM  Investor Expectations to Drive Momentum within Atomera, YogaWorks, Cellect Biotechnology, Eyegate Pharmaceuticals, Zealand Pharma A/S, and Polar Power Discovering Underlying Factors of Influence GlobeNewswire -5.21%
Nov-13-18 07:00AM  Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2018 Financial Results PR Newswire
Nov-05-18 07:00AM  Cellect Receives Multiple Patent Grants PR Newswire
Nov-01-18 07:00AM  Cellect to Present Its Breakthrough Stem Cell Production Technology at the BIO-Europe PR Newswire +6.82%
Oct-22-18 08:00AM  Cellect Announces a Major Technological Breakthrough for Industrialization of Apotainer Stem Cell Product Line PR Newswire
Oct-18-18 07:00AM  Positive Results of Orthopedic Treatment With the Use of ApoGraft Enriched Stem Cells Derived From Fat Tissues PR Newswire
Oct-15-18 07:16AM  Cellect Announces Positive Clinical Results PR Newswire
Aug-20-18 07:00AM  Cellect Receives Notice of Allowance for Stem Cell Selection Technology Patent in Korea PR Newswire
Aug-13-18 07:00AM  Cellect and Cell2in Launch Collaboration to Significantly Improve Stem Cell Selection and Expansion PR Newswire
Aug-09-18 04:15PM  Cellect Biotechnology Provides Corporate Update and Reports Second Quarter 2018 Financial Results PR Newswire
Aug-07-18 07:00AM  Cellect Granted Key European Patent for Its Stem Cell Selection Technology PR Newswire
Jul-09-18 07:00AM  Cellect Signed Strategic Agreement with Swiss Biotech Center (SBC) PR Newswire
Jul-05-18 07:00AM  Cellect Signs Collaboration Agreement With Dresden University denovoMATRIX Team PR Newswire
May-17-18 04:59PM  Cellect Biotechnology Ltd Provides Corporate Update and Reports First Quarter 2018 Financial Results PR Newswire
May-10-18 07:00AM  Former GE Healthcare Executive to Join Cellect as Chief Business Officer PR Newswire
Apr-09-18 07:00AM  Cellect Announces a Major Milestone for Enabling Stem Cells Production PR Newswire +7.65%
Mar-19-18 04:15PM  Cellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results PR Newswire
Feb-01-18 12:00PM  Frost & Sullivan Publishes an Update Report on Cellect Biotechnology Ltd.: Capital raising of $4M will support the company's clinical and strategic goals; price target unchanged PR Newswire
11:43AM  Frost & Sullivan Publishes an Update Report on Cellect Biotechnology Ltd.: Capital raising of $4M will support the company's clinical and strategic goals; price target unchanged PR Newswire
Jan-29-18 08:00AM  Cellect Biotechnology Announces $4 Million Registered Direct Offering PR Newswire -5.19%
Jan-16-18 07:00AM  Cellect Announces Opening of a Second Clinical Trial Site and Approval from Safety Board (DSMB) for Dose Escalation PR Newswire
Jan-05-18 01:11PM  Cellect stock rockets 40% on breakthrough trial announcement but results are for just three patients MarketWatch
Jan-04-18 08:52AM  UPDATE: Cellect Biotech shares rocket 79% premarket after unveiling stem cell breakthrough MarketWatch +37.78%
07:45AM  Cellect Announces Breakthrough Clinical Results PR Newswire
Nov-22-17 07:00AM  Cellect Biotechnology Ltd Provides Corporate Update and Reports Third Quarter 2017 Financial Results PR Newswire
Nov-10-17 07:00AM  Cellect CEO, Dr. Shai Yarkoni Selected as Keynote Speaker at the 11th World Congress of Regenerative Medicine & Stem Cell in Singapore PR Newswire
Oct-31-17 08:58AM  Cellect Chosen Among Selected Global Leaders Presenting at Bio-Europe 2017 Conference Addressing over 3,800 Industry Specialists from Over 2,000 World Leading Companies PR Newswire
Oct-25-17 10:51AM  Cellect Biotechnology Ltd. (APOP) Celebrates Major Milestone SmarterAnalyst
07:00AM  Cellect Announces a Major Breakthrough of its ApoGraft Technology: Reporting Today Positive Results from a 20 Patients Trial With Tel-Aviv Ichilov Medical Center PR Newswire
Oct-19-17 07:05AM  Cellect Appoints Dr. Ronit Bakimer-Kleiner as Chief Development Officer PR Newswire
Sep-15-17 07:40AM  Corporate News Blog - Amicus Therapeutics Reports Phase-3 Results for Sd-101 in Epidermolysis Bullosa did not Meet Primary Endpoints ACCESSWIRE
Sep-14-17 07:50AM  Corporate News Blog - Sage Therapeutics Announces Top-Line Results from Phase-3 STATUS Trial of Brexanolone ACCESSWIRE
Sep-07-17 09:42AM  Cellect Biotechnology Announces $4.3 Million Raise in a Registered Direct Offering PR Newswire
Sep-06-17 08:36AM  Cellect Biotechnology (APOP) Soars: Stock Adds 10.2% in Session Zacks
Sep-05-17 07:38AM  UPDATED: Cellect shares rise 53% after FDA grants its technology orphan drug status MarketWatch
07:19AM  Cellect shares rise 5% after FDA grants its technology orphan drug status MarketWatch
07:02AM  FDA Grants Orphan Drug Status to Cellect's ApoGraft for Acute GvHD and Chronic GvHD PR Newswire
Sep-01-17 07:02AM  Cellect Shares Will Be Traded From Next Week Exclusively on NASDAQ PR Newswire
Aug-21-17 07:02AM  Cellect Biotechnology Ltd Provides Corporate Update and Reports Second Quarter 2017 Financial Results PR Newswire
Aug-07-17 07:00AM  Cellect Engages Locust Walk to Support Business Development Activities for Cellect's ApoGraft PR Newswire
Jun-14-17 08:15AM  Corporate News Blog - Cellect Biotech Gets Patent for Method of Use for Flagship Technology - ApoGraft(TM) Accesswire
07:32AM  Following the US, Cellect Receives Russian Patent Covering Any Device and Method Using Cellect's Flagship Technology - the ApoGraft PR Newswire
Jun-12-17 07:05AM  Cellect Receives Notice of Allowance from the US Patent & Trademark Office PR Newswire
Jun-09-17 09:47AM  Cellect is Moving to Trade Exclusively on the NASDAQ PR Newswire
May-29-17 07:00AM  Cellect Biotechnology Ltd Provides Corporate Update and Reports First Quarter 2017 Financial Results PR Newswire
May-23-17 07:00AM  David Braun, Head of Merck Device Business (MD&S), Joins Cellect's Advisory Board PR Newswire
May-03-17 07:01AM  Cellect Gets Green Light From FDA For ApoGraft IND Submission in the U.S. GlobeNewswire
Apr-05-17 09:27AM  Q1 Roundup: Winners and Losers of Biotech Sector Investopedia
09:27AM  Q1 Roundup: Winners and Losers of Biotech Sector
Apr-04-17 08:30AM  Cellect Biotechnology (APOP) Jumps: Stock Moves 10.5% Higher Zacks
08:30AM  Cellect Biotechnology (APOP) Jumps: Stock Moves 10.5% Higher
Apr-03-17 12:49PM  Cellect Biotechnology Gets European Patent Investopedia
12:49PM  Cellect Biotechnology Gets European Patent at Investopedia
06:02AM  Cellect Receives Notice of Intention to Grant from European Patent Office for Patent Protecting Companys Technology in Multiple Indications GlobeNewswire
Mar-28-17 09:30AM  Cellect Biotechnology and Impax Laboratories Post Solid Gains Accesswire
Mar-27-17 03:17PM  Why Cellect Biotechnology Stock Is Skyrocketing Today Motley Fool
03:17PM  Why Cellect Biotechnology Stock Is Skyrocketing Today at Motley Fool
02:43PM  Cellect Biotech stock rises 71% after announcing successful stem cell transplant procedure MarketWatch
02:43PM  Cellect Biotech stock rises 71% after announcing successful stem cell transplant procedure at MarketWatch
11:26AM  Cellect Succeeds in First Stem Cell Transplant Investopedia
11:26AM  Cellect Succeeds in First Stem Cell Transplant at Investopedia
07:02AM  Cellect Announces Successful First Cancer Patient Stem Cell Transplant GlobeNewswire
Mar-23-17 07:05AM  Cellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial Results GlobeNewswire
Mar-02-17 07:01AM  Michael Berelowitz MD., Former Head, Clinical Development and Medical Affairs, Pfizer Specialty Care Business Unit Joins Cellects Board of Directors GlobeNewswire
Feb-23-17 11:00AM  Cellect to Ring the NASDAQ Stock Market Opening Bell on Friday, February 24th GlobeNewswire
10:00AM  Cellect Biotechnology Ltd. (Nasdaq: APOP) to Ring The Nasdaq Stock Market Opening Bell GlobeNewswire
07:00AM  World-Renowned Stem Cell Transplantation Expert joins Cellects Advisory Board GlobeNewswire
Feb-21-17 11:10AM  Tuesdays Top Biopharma Movers
07:01AM  Cellect Announces Positive Clinical Trial Results GlobeNewswire
Feb-15-17 09:30AM  Biotech Industry Poised for a Breakout in 2017? Today's Reports on Cellect Biotechnology and XOMA Accesswire
Feb-14-17 04:01PM  Dual-Listed Cellect to Voluntarily File for Delisting from Tel Aviv Stock Exchange GlobeNewswire
Feb-08-17 01:12PM  Why Cellect Biotechnology Ltd Shares Skyrocketed Higher Today at Motley Fool
11:35AM  Wednesdays Biggest Biopharma Movers
07:05AM  First Cancer Patient Treated In Phase I/II Trial of ApoGraft GlobeNewswire
Feb-03-17 09:30AM  Mergers & Acquisitions Could be a Key Catalyst for Biotech Stocks in 2017: Today's Reports on Cellect Biotechnology and Celldex Therapeutics Accesswire
Jan-30-17 04:15PM  Dr. Yaron Pereg Appointed as New Chief Development Officer GlobeNewswire
Jan-12-17 03:48PM  Thursdays Biggest Biopharma Winners
08:00AM  Cellect Receives Patent Notice of Allowance from US Patent & Trademark Office Protecting Companys Technology in Multiple Key Indications GlobeNewswire
Cellect Biotechnology Ltd., a biotechnology company, engages in developing ApoGraft, a technology platform that functionally selects stem cells to enhance the safety of regenerative medicine and stem cell therapies in Israel. It is developing the ApoTainer selection kit, a shelf stem cell selection kit for allogeneic hematopoietic stem cell transplantation procedures for patients suffering from hematological malignancies. The company has collaborations with the denovoMATRIX group of the Technische Universitat Dresden to conduct examinations into the tentative synergy between ApoGraft and denovoMAtrix technology for the purpose of evaluating collaborative development of products for regenerative medicine; and Cell2in Inc. to conduct scientific evaluations combining ApoGraft with Cell2in's identification technology FreSHtracer, which monitors stem cell quality by utilizing a fluorescent dye to characterize their oxidative stress state. It also has a collaboration with the Washington University School of Medicine to determine the safety and tolerability of ApoGraft for bone marrow transplantations in the United States. The company was formerly known as Cellect Biomed Ltd. and changed its name to Cellect Biotechnology Ltd. in July 2016. Cellect Biotechnology Ltd. was founded in 2011 and is headquartered in Kfar Saba, Israel.